A Ceftriaxone, Disodium Salt, Hemiheptahydrate CEP of the European Pharmacopoeia monograph is often referred to as a Ceftriaxone, Disodium Salt, Hemiheptahydrate Certificate of Suitability (COS). The purpose of a Ceftriaxone, Disodium Salt, Hemiheptahydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ceftriaxone, Disodium Salt, Hemiheptahydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ceftriaxone, Disodium Salt, Hemiheptahydrate to their clients by showing that a Ceftriaxone, Disodium Salt, Hemiheptahydrate CEP has been issued for it. The manufacturer submits a Ceftriaxone, Disodium Salt, Hemiheptahydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ceftriaxone, Disodium Salt, Hemiheptahydrate CEP holder for the record. Additionally, the data presented in the Ceftriaxone, Disodium Salt, Hemiheptahydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ceftriaxone, Disodium Salt, Hemiheptahydrate DMF.
A Ceftriaxone, Disodium Salt, Hemiheptahydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ceftriaxone, Disodium Salt, Hemiheptahydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ceftriaxone, Disodium Salt, Hemiheptahydrate suppliers with CEP (COS) on PharmaCompass.